Quantum-Si & IDEX Health Partner to Advance Proteus Proteomics Platform

Quantum-Si Incorporated, the protein sequencing firm, and IDEX Health & Science, LLC, announced a collaboration to develop and manufacture the optics module for Quantum-Si's innovative proteomics platform, Proteus. IDEX Health & Science, LLC stands as the worldwide leader in life science optics, fluidics, and microfluidics, providing customers with a threefold benefit through the implementation of optofluidic pathways via strategic collaborations, innovative solutions, and established expertise. 

IDEX Health & Science provides the widest and most comprehensive solution for customer optical requirements through its Melles Griot and Semrock product ranges. From individual lasers, optics, optical filtering components, and pre-assembled optics and photonics modules, to research and design expertise, along with scalable production capabilities in an ISO9001 certified facility. In this collaboration, IDEX Health & Science will assist in the design and creation of the Proteus optics module and act as the producer.

“We are thrilled to enter into this partnership with IDEX Health & Science and leverage their industry leading expertise in the development and manufacturing of complex optical systems for life sciences instrumentation,” said Jeff Hawkins, president and chief executive officer of Quantum-Si. “Being able to have IDEX Health & Science’s unique experience and world class technical team involved in the Proteus instrument program at this key phase of development, further increases our confidence in delivering this novel platform to market by the second half of 2026.”